BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Verstappen GM, Kroese FGM, Bootsma H. T cells in primary Sjögren's syndrome: targets for early intervention. Rheumatology (Oxford) 2019:kez004. [PMID: 30770920 DOI: 10.1093/rheumatology/kez004] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 12.7] [Reference Citation Analysis]
Number Citing Articles
1 Zeng W, Zhou X, Yu S, Liu R, Quek CWN, Yu H, Tay RYK, Lin X, Feng Y. The Future of Targeted Treatment of Primary Sjögren’s Syndrome: A Focus on Extra-Glandular Pathology. IJMS 2022;23:14135. [DOI: 10.3390/ijms232214135] [Reference Citation Analysis]
2 An Q, Zhao J, Zhu X, Yang B, Wu Z, Su Y, Zhang L, Xu K, Ma D. Exploiting the role of T cells in the pathogenesis of Sjögren’s syndrome for therapeutic treatment. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.995895] [Reference Citation Analysis]
3 Murray-Brown W, Guo Y, Small A, Lowe K, Weedon H, Smith MD, Lester SE, Proudman SM, Rao NL, Hao LY, Nagpal S, Wechalekar MD. Differential expansion of T peripheral helper cells in early rheumatoid arthritis and osteoarthritis synovium. RMD Open 2022;8:e002563. [PMID: 36270740 DOI: 10.1136/rmdopen-2022-002563] [Reference Citation Analysis]
4 Mauduit O, Delcroix V, Umazume T, de Paiva CS, Dartt DA, Makarenkova HP. Spatial transcriptomics of the lacrimal gland features macrophage activity and epithelium metabolism as key alterations during chronic inflammation. Front Immunol 2022;13:1011125. [DOI: 10.3389/fimmu.2022.1011125] [Reference Citation Analysis]
5 Sarkar I, Davies R, Aarebrot AK, Solberg SM, Petrovic A, Joshi AM, Bergum B, Brun JG, Hammenfors D, Jonsson R, Appel S. Aberrant signaling of immune cells in Sjögren’s syndrome patient subgroups upon interferon stimulation. Front Immunol 2022;13:854183. [DOI: 10.3389/fimmu.2022.854183] [Reference Citation Analysis]
6 Chen W, Yang F, Lin J. Tph Cells Expanded in Primary Sjögren’s Syndrome. Front Med 2022;9. [DOI: 10.3389/fmed.2022.900349] [Reference Citation Analysis]
7 Yue C, Gao S, Li S, Xing Z, Qian H, Hu Y, Wang W, Hua C. TIGIT as a Promising Therapeutic Target in Autoimmune Diseases. Front Immunol 2022;13:911919. [DOI: 10.3389/fimmu.2022.911919] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Guo X, Dang W, Li N, Wang Y, Sun D, Nian H, Wei R. PPAR-α Agonist Fenofibrate Ameliorates Sjögren Syndrome-Like Dacryoadenitis by Modulating Th1/Th17 and Treg Cell Responses in NOD Mice. Invest Ophthalmol Vis Sci 2022;63:12. [PMID: 35687344 DOI: 10.1167/iovs.63.6.12] [Reference Citation Analysis]
9 Li L, Jasmer KJ, Camden JM, Woods LT, Martin AL, Yang Y, Layton M, Petris MJ, Baker OJ, Weisman GA, Petris CK. Early Dry Eye Disease Onset in a NOD.H-2h4 Mouse Model of Sjögren's Syndrome. Invest Ophthalmol Vis Sci 2022;63:18. [PMID: 35727180 DOI: 10.1167/iovs.63.6.18] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Liao R, Yang HT, Li H, Liu LX, Li K, Li JJ, Liang J, Hong XP, Chen YL, Liu DZ. Recent Advances of Salivary Gland Biopsy in Sjögren's Syndrome. Front Med (Lausanne) 2021;8:792593. [PMID: 35083248 DOI: 10.3389/fmed.2021.792593] [Reference Citation Analysis]
11 Gupta S, Li D, Ostrov DA, Nguyen CQ. Blocking IAg7 class II major histocompatibility complex by drug-like small molecules alleviated Sjögren's syndrome in NOD mice. Life Sci 2022;288:120182. [PMID: 34843735 DOI: 10.1016/j.lfs.2021.120182] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Price E. Biologics in Sjogren’s Syndrome. Handbook of Biologics for Rheumatological Disorders 2022. [DOI: 10.1007/978-981-16-7200-2_7] [Reference Citation Analysis]
13 Yang XX, Yang C, Wang L, Zhou YB, Yuan X, Xiang N, Wang YP, Li XM. Molecular Mechanism of Sphingosine-1-Phosphate Receptor 1 Regulating CD4+ Tissue Memory in situ T Cells in Primary Sjogren's Syndrome. Int J Gen Med 2021;14:6177-88. [PMID: 34611431 DOI: 10.2147/IJGM.S327304] [Reference Citation Analysis]
14 Gao S, Wang Y, Li Y, Xiao D, Lin Y, Chen Y, Cai X. Tetrahedral Framework Nucleic Acids Reestablish Immune Tolerance and Restore Saliva Secretion in a Sjögren's Syndrome Mouse Model. ACS Appl Mater Interfaces 2021;13:42543-53. [PMID: 34477358 DOI: 10.1021/acsami.1c14861] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
15 Chen Y, Dana R. Autoimmunity in dry eye disease - An updated review of evidence on effector and memory Th17 cells in disease pathogenicity. Autoimmun Rev 2021;20:102933. [PMID: 34509656 DOI: 10.1016/j.autrev.2021.102933] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
16 Verstappen GM, Gao L, Pringle S, Haacke EA, van der Vegt B, Liefers SC, Patel V, Hu Y, Mukherjee S, Carman J, Menard LC, Spijkervet FKL, Vissink A, Bootsma H, Kroese FGM. The Transcriptome of Paired Major and Minor Salivary Gland Tissue in Patients With Primary Sjögren's Syndrome. Front Immunol 2021;12:681941. [PMID: 34295332 DOI: 10.3389/fimmu.2021.681941] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
17 Wang Y, Xiao J, Duan Y, Miao M, Huang B, Chen J, Cheng G, Zhou X, Jin Y, He J, Li Z, So KF. Lycium barbarum Polysaccharide Ameliorates Sjögren's Syndrome in a Murine Model. Mol Nutr Food Res 2021;65:e2001118. [PMID: 33825332 DOI: 10.1002/mnfr.202001118] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
18 Hu P, Ming B, Wu X, Cai S, Tang J, Dong Y, Zhou T, Tan Z, Zhong J, Zheng F, Dong L. Intratracheal Poly(I:C) Exposure Accelerates the Immunological Disorder of Salivary Glands in Sjogren's-Like NOD/ShiLtJ Mice. Front Med (Lausanne) 2021;8:645816. [PMID: 33928105 DOI: 10.3389/fmed.2021.645816] [Reference Citation Analysis]
19 Tseng YC, Yang HY, Lin WT, Chang CB, Chien HC, Wang HP, Chen CM, Wang JT, Li C, Wu SF, Hsieh SC. Salivary dysbiosis in Sjögren's syndrome and a commensal-mediated immunomodulatory effect of salivary gland epithelial cells. NPJ Biofilms Microbiomes 2021;7:21. [PMID: 33707430 DOI: 10.1038/s41522-021-00192-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
20 Barcelos F, Martins C, Monteiro R, Cardigos J, Prussiani T, Sítima M, Alves N, Vaz-Patto J, Cunha-Branco J, Borrego LM. Association between EBV serological patterns and lymphocytic profile of SjS patients support a virally triggered autoimmune epithelitis. Sci Rep 2021;11:4082. [PMID: 33603079 DOI: 10.1038/s41598-021-83550-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 Chatzis L, Vlachoyiannopoulos PG, Tzioufas AG, Goules AV. New frontiers in precision medicine for Sjogren's syndrome. Expert Rev Clin Immunol 2021;17:127-41. [PMID: 33478279 DOI: 10.1080/1744666X.2021.1879641] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
22 Hong X, Meng S, Tang D, Wang T, Ding L, Yu H, Li H, Liu D, Dai Y, Yang M. Single-Cell RNA Sequencing Reveals the Expansion of Cytotoxic CD4+ T Lymphocytes and a Landscape of Immune Cells in Primary Sjögren's Syndrome. Front Immunol 2020;11:594658. [PMID: 33603736 DOI: 10.3389/fimmu.2020.594658] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 19.0] [Reference Citation Analysis]
23 Oyelakin A, Horeth E, Song EC, Min S, Che M, Marzullo B, Lessard CJ, Rasmussen A, Radfar L, Scofield RH, Lewis DM, Stone DU, Grundahl K, De Rossi SS, Kurago Z, Farris AD, Sivils KL, Sinha S, Kramer JM, Romano RA. Transcriptomic and Network Analysis of Minor Salivary Glands of Patients With Primary Sjögren's Syndrome. Front Immunol 2020;11:606268. [PMID: 33488608 DOI: 10.3389/fimmu.2020.606268] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
24 Sugioka K, Goto H, Sugita K, Habe K, Yamanaka K, Yamamoto O. Palisaded neutrophilic granulomatous dermatitis, interstitial granulomatous dermatitis and IgA vasculitis associated with incomplete Sjögren's syndrome. J Dermatol 2021;48:556-8. [PMID: 33406284 DOI: 10.1111/1346-8138.15738] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Kiripolsky J, Kramer JM. Innate Immune Dysregulation in Sjögren’s Syndrome. Sjögren's Syndrome and Oral Health 2021. [DOI: 10.1007/978-3-030-72029-2_5] [Reference Citation Analysis]
26 Srivastava A, Makarenkova HP. Innate Immunity and Biological Therapies for the Treatment of Sjögren's Syndrome. Int J Mol Sci 2020;21:E9172. [PMID: 33271951 DOI: 10.3390/ijms21239172] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
27 Ríos-Ríos WJ, Sosa-Luis SA, Torres-Aguilar H. T Cells Subsets in the Immunopathology and Treatment of Sjogren's Syndrome. Biomolecules 2020;10:E1539. [PMID: 33187265 DOI: 10.3390/biom10111539] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
28 Colafrancesco S, Vomero M, Iannizzotto V, Minniti A, Barbati C, Arienzo F, Mastromanno L, Colasanti T, Izzo R, Nayar S, Pipi E, Cerbelli B, Giordano C, Ciccia F, Conti F, Valesini G, Barone F, Priori R, Alessandri C. Autophagy occurs in lymphocytes infiltrating Sjögren's syndrome minor salivary glands and correlates with histological severity of salivary gland lesions. Arthritis Res Ther 2020;22:238. [PMID: 33050949 DOI: 10.1186/s13075-020-02317-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
29 Deng C, Chen Y, Li W, Peng L, Luo X, Peng Y, Zhao L, Wu Q, Zhang W, Zhang X, Fei Y. Alteration of CD226/TIGIT immune checkpoint on T cells in the pathogenesis of primary Sjögren's syndrome. Journal of Autoimmunity 2020;113:102485. [DOI: 10.1016/j.jaut.2020.102485] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
30 Yamamoto T. Psoriasis and Connective Tissue Diseases. Int J Mol Sci 2020;21:E5803. [PMID: 32823524 DOI: 10.3390/ijms21165803] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
31 Zhang H, Zhang H, Gao D, Xie W, Geng Y, Zhang Z. Overlapping Sjogren's syndrome reduces the probability of reaching target in rheumatoid arthritis patients: a propensity score matched real-world cohort from 2009 to 2019. Arthritis Res Ther 2020;22:100. [PMID: 32357906 DOI: 10.1186/s13075-020-02189-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
32 van Nimwegen JF, Mossel E, van Zuiden GS, Wijnsma RF, Delli K, Stel AJ, van der Vegt B, Haacke EA, Olie L, Los LI, Verstappen GM, Pringle SA, Spijkervet FKL, Kroese FGM, Vissink A, Arends S, Bootsma H. Abatacept treatment for patients with early active primary Sjögren's syndrome: a single-centre, randomised, double-blind, placebo-controlled, phase 3 trial (ASAP-III study). The Lancet Rheumatology 2020;2:e153-63. [DOI: 10.1016/s2665-9913(19)30160-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 17.0] [Reference Citation Analysis]
33 Limaye VS, Cash K, Smith C, Koszyca B, Patel S, Greenberg SA, Hissaria P. Inclusion-body myositis and primary Sjögren syndrome: mechanisms for shared etiologies. Muscle Nerve 2020;61:570-4. [PMID: 32035011 DOI: 10.1002/mus.26830] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Huang Y, Yang G, Fei J, Wu Y, Yan J. Bufotalin ameliorates experimental Sjögren's syndrome development by inhibiting Th17 generation. Naunyn Schmiedebergs Arch Pharmacol 2020;393:1977-85. [PMID: 31950221 DOI: 10.1007/s00210-020-01817-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
35 Lu X, Li N, Zhao L, Guo D, Yi H, Yang L, Liu X, Sun D, Nian H, Wei R. Human umbilical cord mesenchymal stem cells alleviate ongoing autoimmune dacryoadenitis in rabbits via polarizing macrophages into an anti-inflammatory phenotype. Exp Eye Res 2020;191:107905. [PMID: 31891674 DOI: 10.1016/j.exer.2019.107905] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]